Navigation Links
IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
Date:8/6/2009

MOUNTAIN VIEW, Calif., Aug. 6 /PRNewswire-FirstCall/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its second quarter 2009 financial results after the market closes on Thursday, August 13, 2009. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, August 13, 2009 to discuss the results of the quarter and other business developments.

Interested parties may access the live conference call via telephone by dialing (877) 941-0843 U.S. or (480) 629-9643 (International) and quoting Conference ID 4133387, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, August 13, 2009 through Thursday, August 20, 2009 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4133387.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, consumable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IRIDEX Reports First Quarter 2009 Financial Results
2. IRIDEX Announces First Quarter 2009 Conference Call and Release Date
3. IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
4. IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results
5. IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
6. IRIDEX Reports Third Quarter 2008 Financial Results
7. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
8. IRIDEX Reports First Quarter 2008 Financial Results
9. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
10. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
11. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: